SCHEMBL24671755

SCHEMBL24671755

CCC1CCN(C(=O)C2CCN(C)CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
LMNA P02545 1/20 0.42
GNAI3 P08754 3/20 0.42
GNAO1 P09471 3/20 0.42
GNAI1 P63096 3/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
DPP8 Q6V1X1 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
HSD11B1 P28845 1/20 0.39
NAMPT P43490 1/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
NCF1 P14598 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26790983 0.90 HPGD (0.45) HTTALDH1A1SMN1; SMN2DPP8DPP7
SCHEMBL22874706 0.85 SMN1; SMN2 (0.46) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL17715716 0.85 HSD11B1 (0.56) LMNAALDH1A1SMN1; SMN2HSD11B1
SCHEMBL25512071 0.84 HTT (0.41) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL20159571 0.84 HTT (0.45) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL25489003 0.83 HRH3 (0.54) ALDH1A1SMN1; SMN2DPP8DPP7HSD11B1
SCHEMBL26263853 0.81 SMN1; SMN2 (0.57) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL24334511 0.81 SMN1; SMN2 (0.57) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL27263531 0.80 GNAI3 (0.52) HTTLMNAGNAI3GNAO1GNAI1
SCHEMBL19176806 0.79 HPGD (0.52) HTTLMNAALDH1A1SMN1; SMN2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed